Geneticist involvement correlates with higher testing uptake and diagnostic yield in perinatal demise cases.
This cohort study analyzed 111 perinatal demise cases to evaluate the impact of geneticist involvement. The primary outcomes assessed included testing uptake, diagnostic yield, and patient education. The comparator group consisted of cases without geneticist involvement. Ascertainment bias was identified as a key limitation in this observational design.
Results indicated that geneticist involvement correlated with significant increases in testing uptake, where 54% of cases received genetic testing (p=0.007). Diagnostic yield and patient education also showed significant increases (p<0.001) in cases with geneticist involvement. However, the likelihood of receiving genetic testing was decreased for cases involving second trimester stillbirths and those with fewer ultrasound abnormalities (p<0.001). Similarly, receipt of a genetics consult was less likely in cases with second trimester stillbirths (p<0.001) and fewer ultrasound abnormalities (p=0.020).
Safety and tolerability data were not reported for this study. The authors note that ascertainment bias may influence the results. Despite these limitations, the practice relevance underscores the importance of integrating genetics providers into perinatal postmortem healthcare teams. The study does not establish causality, as geneticist involvement correlates with outcomes rather than causing them.